CERE Shares Outstanding History Table | ||||||||||||||||||
Also see: CERE Market Cap History CERE YTD Return |
CERE Shares Outstanding History Table | ||||||||||||||||||
Also see: CERE Market Cap History CERE YTD Return |
CERE Shares Outstanding History Chart | |||||||||||||||||||
+10.81% CAGR Mouse over chart for data details
|
CERE Stock Price Chart |
About Cerevel Therapeutics Holdings Inc |
Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. We show 8 historical shares outstanding datapoints in our coverage of CERE's shares outstanding history. Understanding the changing numbers of CERE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CERE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CERE by allowing them to research CERE shares outstanding history as well as any other stock in our coverage universe. |
CERE Current Stock Quote |
Free CERE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
CERE Share Performance |
Shares Outstanding Peers |
Cerevel Therapeutics Holdings (CERE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CERS Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.